id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-P-0172-0006,FDA,FDA-2010-P-0172,"FDA/CDER to Lachman Consultant Services, Inc. Response Letter",Other,LET-Letter,2010-12-14T05:00:00Z,2010,12,2010-12-14T05:00:00Z,,2013-08-11T03:12:10Z,,0,0,0900006480bb6372
FDA-2010-P-0172-0005,FDA,FDA-2010-P-0172,Determinations that Drug Products Not Withdrawn from Sale for Reasons of Safety or Effectiveness: AUGMENTIN 125 (Amoxicillin; Clavulanate Potassium) Chewable Tablet and Six Other AUGMENTIN (Amoxicillin; Clavulanate Potassium),Notice,N-Notice,2010-12-07T05:00:00Z,2010,12,2010-12-07T05:00:00Z,,2010-12-07T17:42:31Z,2010-30622,0,0,0900006480bb0c74
FDA-2010-P-0172-0004,FDA,FDA-2010-P-0172,"Intermin Respponse to EAS Consulting Group, LLC",Other,LET-Letter,2010-09-27T04:00:00Z,2010,9,2010-09-27T04:00:00Z,,2013-08-11T01:37:13Z,,0,0,0900006480b610b9
FDA-2010-P-0172-0003,FDA,FDA-2010-P-0172,"Acknowledgement Letter to Aurobindo Pharmaceuticals, Ltd., (EAS Consulting Group, LLC)",Other,ACK-Acknowledgement Letter,2010-03-29T04:00:00Z,2010,3,2010-03-29T04:00:00Z,,2013-08-11T01:33:21Z,,0,0,0900006480ac6f51
FDA-2010-P-0172-0002,FDA,FDA-2010-P-0172,"Enclosure - ""Approved Drug Products List, Discontinued Drug Product List"" - [Aurobindo Pharmaceuticals, Ltd., (EAS Consulting Group, LLC) - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2010-03-29T04:00:00Z,2010,3,,,2010-03-29T22:24:05Z,,0,0,0900006480ac6f4f
FDA-2010-P-0172-0001,FDA,FDA-2010-P-0172,"Aurobindo Pharmaceuticals, Ltd., (EAS Consulting Group, LLC) - Citizen Petition",Other,CP-Citizen Petition,2010-03-29T04:00:00Z,2010,3,2010-03-29T04:00:00Z,,2013-07-27T23:13:04Z,,0,0,0900006480ac6f4d